S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
ACB   3.58 (-2.98%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
ACB   3.58 (-2.98%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Denali Therapeutics SEC Filings & 10K Form (NASDAQ:DNLI)

$16.03
+0.86 (+5.67 %)
(As of 10/22/2019 04:00 PM ET)
Today's Range
$15.22
Now: $16.03
$16.44
50-Day Range
$14.40
MA: $16.68
$19.59
52-Week Range
$13.78
Now: $16.03
$28.86
Volume1.40 million shs
Average Volume357,285 shs
Market Capitalization$1.54 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.15

SEC Filings

Denali Therapeutics (NASDAQ:DNLI) SEC Filings

DateFilerForm TypeView
09/11/2019
3:38 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
5:51 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
6:49 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
6:49 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
6:48 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
7:49 PM
Denali Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
7:47 PM
ARCH Venture Fund VIII, L.P. (Reporting)
ARCH Venture Partners VIII, L.P. (Reporting)
ARCH Venture Partners VIII, LLC (Reporting)
BYBEE CLINTON (Reporting)
CRANDELL KEITH (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
5:35 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
3:54 PM
Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:33 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2019
4:08 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
4:07 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2019
3:47 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:14 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:13 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
4:15 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
6:30 PM
Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
4:15 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2019
4:00 PM
Denali Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:43 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:39 PM
Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:38 PM
Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:36 PM
Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:34 PM
Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
5:28 PM
Cole Douglas G. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2019
4:52 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:37 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2019
4:34 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4/A
05/08/2019
3:36 PM
Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
3:33 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
5:30 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2019
3:38 PM
Denali Therapeutics (Filer)
Form DEFA14A
04/18/2019
3:36 PM
Denali Therapeutics (Filer)
Form DEF 14A
04/11/2019
4:29 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2019
8:27 PM
Bratton Capital Inc. (Reporting)
Bratton Capital Management, L.P. (Reporting)
BRATTON DOUGLAS K (Reporting)
Denali Therapeutics (Issuer)
Neuro Line Partners LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:08 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
6:03 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
6:02 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
4:49 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
5:02 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2019
12:53 PM
Denali Therapeutics (Filer)
Form S-3ASR
03/12/2019
8:09 PM
Denali Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/12/2019
3:47 PM
Denali Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
8:13 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2019
5:18 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
1:10 PM
Denali Therapeutics (Filer)
Form CT ORDER
02/13/2019
10:50 AM
Denali Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
02/12/2019
5:30 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
4:59 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
4:57 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
4:56 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
4:54 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2019
1:04 PM
Denali Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
02/11/2019
9:03 AM
BAILLIE GIFFORD & CO (Filed by)
Denali Therapeutics (Subject)
Form SC 13G/A
02/05/2019
5:28 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2019
5:27 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2019
4:11 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
5:54 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
5:52 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
4:27 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
4:08 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
4:06 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
3:33 PM
Denali Therapeutics (Filer)
Form 10-Q/A
11/19/2018
4:31 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2018
12:14 PM
Denali Therapeutics (Filer)
Form CT ORDER
11/15/2018
5:13 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2018
4:37 PM
Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2018
4:34 PM
Cook Jennifer E. (Reporting)
Denali Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2018
3:38 PM
Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
3:35 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2018
5:08 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2018
5:01 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:59 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2018
4:58 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
4:27 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
4:25 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
4:44 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2018
4:41 PM
Denali Therapeutics (Issuer)
Watts Ryan J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2018
4:45 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2018
4:43 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2018
4:42 PM
Denali Therapeutics (Issuer)
Krognes Steve E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2018
3:38 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2018
4:38 PM
Denali Therapeutics (Issuer)
Schuth Alexander O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
5:31 PM
Denali Therapeutics (Issuer)
NELSEN ROBERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
5:30 PM
Denali Therapeutics (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
5:29 PM
Denali Therapeutics (Issuer)
FLATLEY JAY T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
5:28 PM
Denali Therapeutics (Issuer)
Schenkein David P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
5:27 PM
Cole Douglas G. (Reporting)
Denali Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
5:27 PM
Denali Therapeutics (Issuer)
SATO VICKI L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2018
3:36 PM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2018
7:07 AM
Denali Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2018
7:01 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2018
3:30 PM
Denali Therapeutics (Filer)
Form DEFA14A
04/26/2018
3:26 PM
Denali Therapeutics (Filer)
Form DEF 14A
04/11/2018
10:32 AM
Denali Therapeutics (Issuer)
FMR LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2018
5:29 PM
Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2018
5:25 PM
Denali Therapeutics (Issuer)
Klein Peter S (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2018
7:06 AM
Denali Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/19/2018
7:01 AM
Denali Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2018
6:57 PM
Denali Therapeutics (Issuer)
Ho Carole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel